• 1
    Puli SR, Bechtold ML, Buxbaum JL, Eloubeidi MA. How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: a meta-analysis and systematic review. Pancreas. 2013;42:2026.
  • 2
    Klapman JB, Logrono R, Dye CE, Waxman I. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol. 2003;98:12891294.
    Direct Link:
  • 3
    Hebert-Magee S, Bae S, Varadarajulu S, et al. The presence of a cytopathologist increases the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration cytology for pancreatic adenocarcinoma: a meta-analysis. Cytopathology. 2013;24:159171.
  • 4
    Wani S, Early DS, Mullady D, et al. Cost minimization analysis of onsite cytopathologist (CyP) evaluation during EUS FNA of solid pancreatic lesions (SPL). Gastrointest Endosc. 2013;77:(5 suppl):AB245AB246.
  • 5
    Wani S, Mullady D, Early DS, et al. Clinical impact of immediate on-site cytopathology evaluation during endoscopic ultrasound guided fine needle aspiration (EUS-FNA) of pancreatic mass interim: analysis of a multicenter randomized controled trial. Oral Presentation DDW. 2013.
  • 6
    Weynand B, Borbath I, Galant C, Piessevaux H, Deprez PH. Optimizing specimen collection and laboratory procedures reduces the non-diagnostic rate for endoscopic ultrasound-guided fine-needle aspiration of solid lesions of the pancreas. Cytopathology. 2013;24:177184.